Clinical Trials Directory

Trials / Completed

CompletedNCT03033264

Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.

A Comparison Between Labor Induction With Dinoprostone and a Cervical Ripening Balloon in Women With a BMI>30 as Oppose With a BMI<30.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
164 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

Women with a BMI\>30 and women with a BMI\<30 will be divided in a randomized controlled manor to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files.

Detailed description

The study is a randomized controlled test in which women with a BMI\>30 and women with a BMI\<30 will sign an informed consent and then divided to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. All subjects participating in the study will be induced for obstetrical indications alone. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files. The participants will finish participation in the study after delivery.

Conditions

Interventions

TypeNameDescription
DRUGDinoprostone10 mg of a Dinoprostone vaginal insert.
DEVICEDouble lumen cervical ripening balloon.Double lumen cervical ripening balloon.

Timeline

Start date
2017-01-01
Primary completion
2020-07-31
Completion
2020-10-01
First posted
2017-01-26
Last updated
2020-10-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03033264. Inclusion in this directory is not an endorsement.